NYSE:TDOC

Stock Analysis Report

Executive Summary

Teladoc Health, Inc. provides virtual healthcare services on a business-to-business in the United States and internationally.

Snowflake

Fundamentals

High growth potential with excellent balance sheet.


Similar Companies

Share Price & News

How has Teladoc Health's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

2.5%

TDOC

2.5%

US Healthcare Services

-0.6%

US Market


1 Year Return

-7.6%

TDOC

10.3%

US Healthcare Services

0.6%

US Market

TDOC underperformed the Healthcare Services industry which returned 8.7% over the past year.

TDOC underperformed the Market in United States of America which returned 1.1% over the past year.


Share holder returns

TDOCIndustryMarket
7 Day2.5%2.5%-0.6%
30 Day20.7%-2.9%2.2%
90 Day13.6%-4.1%1.1%
1 Year-7.6%-7.6%10.4%10.3%2.9%0.6%
3 Year287.1%287.1%51.9%51.6%44.6%35.2%
5 Yearn/a52.0%51.1%61.9%44.2%

Price Volatility Vs. Market

How volatile is Teladoc Health's share price compared to the market and industry in the last 5 years?


Simply Wall St News

1 month ago | Simply Wall St

Estimating The Intrinsic Value Of Teladoc Health, Inc. (NYSE:TDOC)

Valuation

Is Teladoc Health undervalued based on future cash flows and its price relative to the stock market?

5.18x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Teladoc Health's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

Teladoc Health's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

Teladoc Health is loss making, we can't compare its value to the US Healthcare Services industry average.

Teladoc Health is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Teladoc Health, we can't assess if its growth is good value.


Price Based on Value of Assets

Teladoc Health is overvalued based on assets compared to the US Healthcare Services industry average.


Next Steps

Future Growth

How is Teladoc Health expected to perform in the next 1 to 3 years based on estimates from 20 analysts?

55.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Teladoc Health's revenue is expected to grow significantly at over 20% yearly.

Teladoc Health's earnings are expected to grow significantly at over 20% yearly.

Teladoc Health's revenue growth is expected to exceed the United States of America market average.

Teladoc Health's earnings growth is expected to exceed the United States of America market average.

Teladoc Health's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Teladoc Health is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has Teladoc Health performed over the past 5 years?

-26.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Teladoc Health does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Teladoc Health's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Teladoc Health's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Teladoc Health has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Teladoc Health has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Teladoc Health improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Teladoc Health's financial position?


Financial Position Analysis

Teladoc Health is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Teladoc Health's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Teladoc Health's level of debt (42.6%) compared to net worth is high (greater than 40%).

The level of debt compared to net worth has been reduced over the past 5 years (43.3% vs 42.6% today).


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 1.2x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Whilst loss making Teladoc Health has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.

Whilst loss making Teladoc Health has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -53.5% per year.


Next Steps

Dividend

What is Teladoc Health's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Teladoc Health's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Teladoc Health's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Teladoc Health has not reported any payouts.

Unable to verify if Teladoc Health's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Teladoc Health has not reported any payouts.


Future Payout to Shareholders

No need to calculate the sustainability of Teladoc Health's dividends in 3 years as they are not expected to pay a notable one for United States of America.


Next Steps

Management

What is the CEO of Teladoc Health's salary, the management and board of directors tenure and is there insider trading?

4.0yrs

Average management tenure


CEO

Jason Gorevic (47yo)

10.3yrs

Tenure

US$7,329,322

Compensation

Mr. Jason N. Gorevic has been Chief Executive Officer at TelaDoc, Inc. (Formerly TelaDoc Medical Services Inc.) since June 2009. Mr. Gorevic serves as Director of Doximity, Inc. since April 2019. Mr. Gorev ...


CEO Compensation Analysis

Jason's remuneration is about average for companies of similar size in United States of America.

Jason's compensation has increased whilst company is loss making.


Management Age and Tenure

4.0yrs

Average Tenure

50yo

Average Age

The tenure for the Teladoc Health management team is about average.


Board Age and Tenure

4.7yrs

Average Tenure

65.5yo

Average Age

The tenure for the Teladoc Health board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

SellUS$71,28015 Mar 19
Michelle Bucaria
EntityIndividual
Shares1,188
Max PriceUS$60.00

Ownership Breakdown


Management Team

  • Jason Gorevic (47yo)

    CEO & Director

    • Tenure: 10.3yrs
    • Compensation: US$7.33m
  • Peter McClennen (50yo)

    President

    • Tenure: 1.8yrs
    • Compensation: US$4.89m
  • George Brooks

    Co-Founder

    • Tenure: 17.7yrs
  • Jeff Nadler (55yo)

    Chief Information Officer

    • Tenure: 0yrs
  • Adam Vandervoort (44yo)

    Chief Legal Officer & Secretary

    • Tenure: 4.6yrs
    • Compensation: US$1.99m
  • Gabriel Cappucci (56yo)

    Chief Accounting Officer

    • Tenure: 4.3yrs
  • David Sides (48yo)

    Chief Operating Officer

    • Tenure: 0.2yrs
  • Stephany Verstraete (50yo)

    Chief Marketing Officer

    • Tenure: 3.7yrs
    • Compensation: US$1.73m
  • Kelsey Turcotte

    Vice President of Investor Relations

    • Tenure: 0yrs
  • Mala Murthy (55yo)

    Chief Financial Officer

    • Tenure: 0.3yrs

Board Members

  • Tom McKinley (67yo)

    Independent Director

    • Tenure: 9.8yrs
    • Compensation: US$246.17k
  • Arneek Multani (45yo)

    Independent Director

    • Tenure: 11.7yrs
    • Compensation: US$248.67k
  • David Shedlarz (71yo)

    Director

    • Tenure: 3yrs
    • Compensation: US$258.67k
  • Michael Goldstein (77yo)

    Independent Director

    • Tenure: 4.6yrs
    • Compensation: US$252.50k
  • David Snow (64yo)

    Chairman

    • Tenure: 4.8yrs
    • Compensation: US$274.34k
  • Bill Frist (67yo)

    Independent Director

    • Tenure: 5yrs
    • Compensation: US$245.17k
  • Jason Gorevic (47yo)

    CEO & Director

    • Tenure: 10.3yrs
    • Compensation: US$7.33m
  • Ken Paulus (59yo)

    Director

    • Tenure: 2.6yrs
    • Compensation: US$240.17k
  • Brian McAndrews (60yo)

    Director

    • Tenure: 2yrs
    • Compensation: US$248.67k
  • Helen Darling (77yo)

    Director

    • Tenure: 3.3yrs
    • Compensation: US$236.17k

Company Information

Teladoc Health, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Teladoc Health, Inc.
  • Ticker: TDOC
  • Exchange: NYSE
  • Founded: 2002
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$5.198b
  • Shares outstanding: 72.04m
  • Website: https://www.teladochealth.com

Number of Employees


Location

  • Teladoc Health, Inc.
  • 2 Manhattanville Road
  • Suite 203
  • Purchase
  • New York
  • 10577
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TDOCNYSE (New York Stock Exchange)YesCommon StockUSUSDJul 2015
4LLDB (Deutsche Boerse AG)YesCommon StockDEEURJul 2015
0LDRLSE (London Stock Exchange)YesCommon StockGBUSDJul 2015

Biography

Teladoc Health, Inc. provides virtual healthcare services on a business-to-business in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, c ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/21 00:19
End of Day Share Price2019/09/20 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.